Matinas BioPharma Holdings, Inc. (MTNB)
USD 0.59
(-0.45%)
USD 0.59
(-0.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.09 Million | 3.18 Million | 33.33 Thousand | 158.33 Thousand | 90 Thousand | 119.75 Thousand |
| Cost of Revenue | 14.48 Million | 16.67 Million | 781.49 Thousand | 14.35 Million | 11.23 Million | 6.78 Million |
| Gross Profit | -13.39 Million | -13.49 Million | -748.15 Thousand | -14.2 Million | -11.14 Million | -6.66 Million |
| Operating Expenses | 24.86 Million | 11.1 Million | 24.76 Million | 24.36 Million | 19.01 Million | 14.76 Million |
| Selling, General and Administrative Expenses | 10.37 Million | 11.1 Million | 10.18 Million | 10 Million | 7.77 Million | 7.97 Million |
| Research and Development Expenses | 14.48 Million | 16.67 Million | 14.58 Million | 14.35 Million | 11.23 Million | 6.78 Million |
| Other Expenses | - | -16.67 Million | 122.87 Thousand | 686.42 Thousand | 541 Thousand | 56.55 Thousand |
| Cost and Expenses | 24.86 Million | 27.77 Million | 24.76 Million | 24.36 Million | 19.01 Million | 14.76 Million |
| Operating Income | -23.76 Million | -24.59 Million | -24.73 Million | -24.2 Million | -18.92 Million | -14.64 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -7.98 Million | -2.1 Million | -1.84 Million | -1.78 Million | -506.92 Thousand |
| Earnings before Tax | -22.94 Million | -20.99 Million | -23.28 Million | -22.44 Million | -17.37 Million | -14.58 Million |
| Net Income | -22.94 Million | -13.01 Million | -21.17 Million | -20.59 Million | -15.58 Million | -14.08 Million |
| Earnings Per Share Basic | -5.28 | -3.00 | -5.04 | -5.23 | -5.37 | -7.18 |
| Earnings Per Share Diluted | -5.28 | -3.00 | -5.04 | -5.23 | -5.37 | -7.18 |
| Weighted Average Shares Outstanding | 4.34 Million | 4.33 Million | 4.2 Million | 3.93 Million | 2.9 Million | 1.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.34 Million | 4.33 Million | 4.2 Million | 3.93 Million | 2.9 Million | 1.96 Million |
| Gross Margin | -12.22 | -4.23 | -22.44 | -89.69 | -123.83 | -55.68 |
| EBIT Margin | -20.83 | -8.81 | -781.90 | -159.66 | -221.42 | -120.49 |
| Profit Margin | -20.93 | -4.08 | -635.21 | -130.10 | -173.17 | -117.60 |
| EBITDA | -22.82 Million | -24.23 Million | -24.45 Million | -23.91 Million | -18.59 Million | -14.42 Million |
| Earnings Before Tax Margin | -21.68 | -7.71 | -742.05 | -152.88 | -210.23 | -122.31 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.09 Million | -1.09 Million | - | - |
| Cost of Revenue | 241 Thousand | 240 Thousand | 941 Thousand | 240 Thousand | 238 Thousand | 234 Thousand |
| Gross Profit | -241 Thousand | -240 Thousand | 155 Thousand | -1.33 Million | -238 Thousand | -234 Thousand |
| Operating Expenses | 5.59 Million | 5.66 Million | 23.92 Million | 5.64 Million | 6.13 Million | 6.15 Million |
| Selling, General and Administrative Expenses | 2.22 Million | 2.21 Million | - | 1.98 Million | 2.83 Million | 2.6 Million |
| Research and Development Expenses | 3.37 Million | 3.44 Million | - | 3.66 Million | 3.29 Million | 3.55 Million |
| Other Expenses | 120 Thousand | 78 Thousand | 340 Thousand | 89 Thousand | 79 Thousand | 99 Thousand |
| Cost and Expenses | 5.83 Million | 5.9 Million | 24.86 Million | 5.88 Million | 6.13 Million | 6.15 Million |
| Operating Income | -5.83 Million | -5.9 Million | -23.76 Million | -5.88 Million | -6.13 Million | -6.15 Million |
| Interest Expense | - | - | - | 73 Thousand | - | - |
| Income Tax Expense | - | 196.72 Thousand | 773.1 Thousand | 311 Thousand | -238 Thousand | 111.91 Thousand |
| Earnings before Tax | -5.71 Million | -5.82 Million | -22.94 Million | -5.31 Million | -6.05 Million | -6.06 Million |
| Net Income | -5.71 Million | -5.82 Million | -22.94 Million | -5.31 Million | -6.05 Million | -6.06 Million |
| Earnings Per Share Basic | -0.02 | -0.03 | - | -0.02 | -0.03 | -0.03 |
| Earnings Per Share Diluted | -0.02 | -0.03 | - | -0.02 | -0.03 | -0.03 |
| Weighted Average Shares Outstanding | 249.35 Million | 217.35 Million | 217.26 Million | 217.26 Million | 217.26 Million | 217.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 249.35 Million | 217.35 Million | 217.26 Million | 217.26 Million | 217.26 Million | 217.26 Million |
| Gross Margin | - | - | 0.14 | 1.22 | - | - |
| EBIT Margin | - | - | - | 5.15 | - | - |
| Profit Margin | - | - | -20.93 | 4.85 | - | - |
| EBITDA | -5.59 Million | -5.66 Million | - | -5.64 Million | -6.13 Million | -5.92 Million |
| Earnings Before Tax Margin | - | - | -21.68 | 5.37 | - | - |
BANKBARODA
DCO
2338
JXMNF
002987
002766